Exagen Inc.(NasdaqGM:XGN) dropped from Russell 2500 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -1.58% | -2.09% | -6.03% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.03% | 32.46M | |
+17.63% | 83.4B | |
-0.07% | 27.04B | |
-11.48% | 16.96B | |
-0.25% | 16.86B | |
+2.89% | 15.76B | |
+1.25% | 12.76B | |
+73.23% | 13.33B | |
+72.58% | 12.74B | |
+1.58% | 12.32B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc.(NasdaqGM: XGN) dropped from Russell 2500 Growth Index